Ambalal Sarabhai Enterprises Limited share price
NSE: AMBALALSA · ISIN INE432A01017
Key numbers
- Market cap
- ₹ 315 Cr
- Current price
- ₹ 41.09
- 52-week high / low
- ₹ 50 / 30
- Stock P/E
- 23.2
- Book value
- ₹ 20.7
- Dividend yield
- 0.00%
- ROCE
- 11.1%
- ROE
- 11.9%
- Debt to equity
- 0.36
- Sales growth (3 yrs)
- 5.8%
- Profit growth (3 yrs)
- 15.8%
- 1-year return
- -
About Ambalal Sarabhai Enterprises Limited
Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures and markets pharmaceutical, molecular diagnostics, and electronic products in India and internationally. The company is involved in the supply of pharmaceutical preparations, such as finished dosage forms and active pharmaceutical ingredients; manufacture of fermentation-based pharmaceutical products; and manufacturing and marketing analytical, laboratory, and test and measuring instruments. It also engages in the marketing and distributing professional broadcast, video, and audio equipment; marketing of generic and veterinary formulations; provision of a portfolio of products, including oncology, fertility, women's healthcare, and other specialty therapeutic segments; and manufacturing and marketing of vitamin C coated products. Ambalal Sarabhai Enterprises Limited was incorporated in 1977 and is based in Ahmedabad, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 47 | 44 | 52 | 65 | 44 |
| Operating profit | 10 | 1 | 4 | 6 | 7 |
| Net profit | 8 | -1 | 3 | 7 | 4 |
| EPS (₹) | 1.07 | -0.07 | 0.40 | 0.85 | 0.52 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.